SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Stock Picking for Charity - 2006
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dr.praveen who wrote (408)6/6/2006 11:00:27 AM
From: kenhott  Read Replies (1) of 592
 
I have personally seen this product (by chance) and I agree with dna-jock about a potentially good product having trouble in the testing phase. My concerns were about safety (For instance, (1) there are millions of echos done per year and (2) nuclear works fine) and if they can get pass the FDA with their two phase 3s, as designed with e.g. N=300 to 400 each. Now they will need help at the FDA even if they hit all the endpoints of their 2nd phase 3. One concern I had was the lack of an adequate partner in the U.S. We may not see this product on market unless someone with size gets behind this product and push.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News